Steris
$208.54Change from previous close: −0.38%Absolute change: −$0.80
At a glance
- Revenue growth
- +8.73%
- FY to Mar 2026 vs FY to Mar 2025
- Net income growth
- +27.27%
- FY to Mar 2026 vs FY to Mar 2025
- Net margin
- 13.2%
- FY to Mar 2025: 11.3%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Mar 2026 | FY to Mar 2025 | FY to Mar 2024 | FY to Mar 2023 | FY to Mar 2022 |
|---|---|---|---|---|---|
| Operating cash flow | 1,341 | 1,148 | 973 | 757 | — |
| Depreciation and amortization | 487 | 476 | 565 | 553 | — |
| Capital expenditure | -369 | -370 | -360 | -362 | — |
| Investing cash flow | -513 | 389 | -887 | -383 | — |
| Financing cash flow | -568 | -1,572 | -85.2 | -499 | — |
| Dividends paid | -242 | -220 | -201 | -183 | — |
| Share repurchases | -236 | -211 | -11.8 | -309 | — |
| Debt issued | 3.0 | — | 182 | 242 | 2,000 |
| Debt repaid | -125 | -1,164 | -60.0 | -248 | — |
| Effect of exchange rates | 7.2 | 0.2 | -2.1 | -14.9 | — |
| Net change in cash | 261 | -35.5 | 0.7 | -125 | — |
| Free cash flow | 972 | 778 | 613 | 395 | — |